Lung damage from cytotoxic drugs
- 1 April 1980
- journal article
- review article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 4 (1), 17-27
- https://doi.org/10.1007/bf00255453
Abstract
Bleomycin, busulphan, and methotrexate are by far the commonest cytotoxic drugs to cause interstitial pneumonitis. However, many other cytotoxic drugs have been reported to produce similar lung damage. Combined effects of these drugs, and of the drugs with other agents that cause lung damage, such as oxygen and radiation, may result in enhancement of lung damage. Early diagnosis, made possible by awareness of this complication and its correct investigation, may reduce severe morbidity and mortality. In some instances, factors that predispose to lung damage are known, and these have been studied in experimental animals.Keywords
This publication has 94 references indexed in Scilit:
- Pulmonary histopathologic changes associated with melphalan therapyCancer, 1978
- Interstitial lung disease in a patient treated with 5-fluorouracil and mitomycin C.BMJ, 1978
- Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapyCancer, 1978
- Ultrastructural study of bleomycin-induced pulmonary changes in miceThe Journal of Pathology, 1978
- Case 12-1978New England Journal of Medicine, 1978
- Pulmonary complications of methotrexate therapyClinical Otolaryngology, 1977
- Cyclophosphamide therapy and interstitial pulmonary fibrosisCancer, 1976
- Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancerCancer, 1976
- Pneumonia and methotrexate.BMJ, 1970
- Busulphan lungThorax, 1969